About Us
Overview
Mission and Vision
Board of Directors
Recognitions
Business Areas
Overview
India - Branded Generics
Emerging Markets - Branded Generics
USA - Generics
Africa - Institution Business
Manufacturing
Overview
Manufacturing facilities
Quality
Environment, Health & Safety
R & D
Investors
Financials
Corporate Governance
Investor Information
Media
Press release
Media Covarage
Media Kit
Career
Life at Ajanta
Work with us
CSR
Contact Us
Search
investor information
Home
Investors
Investor Information
Statutory Communications
Year
2024-25
2023-24
2022-23
2021-22
2020-21
2019-20
2018-19
2017-18
2016-17
2015-16
US FDA Inspection for Paithan Plant
US FDA Inspection of our Dahej Facility
Outcome of Board meeting 18th March 2017
Intimation of BM and Record Date
Clarification on news appearing in media on 24th Jan 2017
Intimation of Board Meeting Q3 2017
Intimation of Board Meeting Q2 2017
1
2
3
>
Related Links
Statutory Communications
Unclaimed Dividend
Unclaimed Shares
Investor Contact
Smart ODR & KYC form
FAQs
Buyback
Miscellaneous
